DrugPatentWatch Database Preview
Sun Pharm Inds Ltd Company Profile
What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?
There are eight US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.
There are thirty-one patent family members on SUN PHARM INDS LTD drugs in nineteen countries and one hundred and thirty-six supplementary protection certificates in thirteen countries.
Summary for Sun Pharm Inds Ltd
| International Patents: | 31 |
| US Patents: | 8 |
| Tradenames: | 89 |
| Ingredients: | 86 |
| NDAs: | 116 |
Drugs and US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 078761-004 | May 11, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 077498-001 | Dec 27, 2007 | OTC | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | RX | No | No | 7,919,483 | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 078464-002 | Apr 8, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Sun Pharm Inds Ltd
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,192,615 | Method for the treatment of acne and certain dosage forms thereof | ➤ Sign Up |
| 6,559,187 | Liquid formulation of metformin | ➤ Sign Up |
| 8,722,650 | Extended-release minocycline dosage forms | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Sun Pharm Inds Ltd Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2004505913 | ➤ Sign Up |
| Japan | 2013213047 | ➤ Sign Up |
| Canada | 2613273 | ➤ Sign Up |
| Japan | 5744976 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| /2008 | Austria | ➤ Sign Up | PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN DER FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE ALS MONOPHOSPHAT, UND METFORMIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: EU/1/08/455/001-014, EU/1/08/456/001-014, EU/1/08/457/001-014 20080716; FIRST REGISTRATION: CH 58450 01-03 20080408 |
| C0008 | Belgium | ➤ Sign Up | PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208 |
| 0714 | Netherlands | ➤ Sign Up | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NATIONAL REGISTRATION NO/DATE: RVG 108438 - 439 20160624; REGISTRATION NO/DATE: BE424286 20120718 BE424295 20120718 |
| 01C/013 | Belgium | ➤ Sign Up | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
